Wearabledevices
FederationofClinicalNeurophysiology(IFCN)recentlypublishedaclinicalpracticeguidelineonauto-
Epilepsy
matedseizuredetectionusingwearabledevices.Weupdatedthesystematicliteraturesearchfortheper-
iodsincethelastsearchbythejointworkinggroup.Weselectedstudiesqualifyingminimallyasphase-2
clinical validation trials, in accordance with standards for testing and validation of seizure detection
devices.
Results: High-levelevidence(phases3and4)isavailableonlyforthedetectionoftonic-clonicseizures
andmajormotorseizureswhenusingwearabledevicesbasedonaccelerometry,surfaceelectromyogra-
phy(EMG),oramultimodaldevicecombiningaccelerometryandheartrate.Thereportedsensitivityof